Logo image of ATEME.PA

ATEME SA (ATEME.PA) Stock Fundamental Analysis

Europe - EPA:ATEME - FR0011992700 - Common Stock

6.06 EUR
+0.4 (+7.07%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

Overall ATEME gets a fundamental rating of 3 out of 10. We evaluated ATEME against 28 industry peers in the Communications Equipment industry. ATEME may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ATEME is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ATEME had negative earnings in the past year.
ATEME had a positive operating cash flow in the past year.
In the past 5 years ATEME reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATEME reported negative operating cash flow in multiple years.
ATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ATEME has a Return On Assets of -4.54%. This is comparable to the rest of the industry: ATEME outperforms 46.43% of its industry peers.
ATEME's Return On Equity of -16.00% is on the low side compared to the rest of the industry. ATEME is outperformed by 60.71% of its industry peers.
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ATEME.PA Yearly ROA, ROE, ROICATEME.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

Looking at the Gross Margin, with a value of 57.97%, ATEME is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
In the last couple of years the Gross Margin of ATEME has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ATEME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
ATEME.PA Yearly Profit, Operating, Gross MarginsATEME.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

ATEME does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEME has more shares outstanding
The number of shares outstanding for ATEME has been increased compared to 5 years ago.
Compared to 1 year ago, ATEME has an improved debt to assets ratio.
ATEME.PA Yearly Shares OutstandingATEME.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ATEME.PA Yearly Total Debt VS Total AssetsATEME.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ATEME has an Altman-Z score of 1.52. This is a bad value and indicates that ATEME is not financially healthy and even has some risk of bankruptcy.
ATEME's Altman-Z score of 1.52 is in line compared to the rest of the industry. ATEME outperforms 53.57% of its industry peers.
ATEME has a debt to FCF ratio of 17.15. This is a negative value and a sign of low solvency as ATEME would need 17.15 years to pay back of all of its debts.
The Debt to FCF ratio of ATEME (17.15) is worse than 75.00% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that ATEME is somewhat dependend on debt financing.
ATEME has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: ATEME underperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Altman-Z 1.52
ROIC/WACCN/A
WACC5.84%
ATEME.PA Yearly LT Debt VS Equity VS FCFATEME.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ATEME has a Current Ratio of 1.49. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
ATEME has a Current ratio (1.49) which is comparable to the rest of the industry.
ATEME has a Quick Ratio of 1.37. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.37, ATEME is doing good in the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.37
ATEME.PA Yearly Current Assets VS Current LiabilitesATEME.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

ATEME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.46%.
Looking at the last year, ATEME shows a decrease in Revenue. The Revenue has decreased by -6.53% in the last year.
Measured over the past years, ATEME shows a small growth in Revenue. The Revenue has been growing by 7.11% on average per year.
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%

3.2 Future

ATEME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.77% yearly.
Based on estimates for the next years, ATEME will show a quite strong growth in Revenue. The Revenue will grow by 8.06% on average per year.
EPS Next Y146.79%
EPS Next 2Y77.13%
EPS Next 3Y56.77%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ATEME.PA Yearly Revenue VS EstimatesATEME.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ATEME.PA Yearly EPS VS EstimatesATEME.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEME. In the last year negative earnings were reported.
ATEME is valuated rather expensively with a Price/Forward Earnings ratio of 23.07.
ATEME's Price/Forward Earnings ratio is in line with the industry average.
ATEME is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 23.07
ATEME.PA Price Earnings VS Forward Price EarningsATEME.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ATEME is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, ATEME is valued a bit more expensive than the industry average as 60.71% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 32.7
EV/EBITDA 364.14
ATEME.PA Per share dataATEME.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ATEME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ATEME's earnings are expected to grow with 56.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.13%
EPS Next 3Y56.77%

0

5. Dividend

5.1 Amount

ATEME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATEME SA

EPA:ATEME (9/26/2025, 7:00:00 PM)

6.06

+0.4 (+7.07%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)09-25 2025-09-25
Earnings (Next)10-30 2025-10-30
Inst Owners16.92%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap70.24M
Analysts86
Price Target7.65 (26.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.07
P/S 0.75
P/FCF 32.7
P/OCF 17.95
P/B 2.09
P/tB 8.2
EV/EBITDA 364.14
EPS(TTM)-0.47
EYN/A
EPS(NY)0.26
Fwd EY4.33%
FCF(TTM)0.19
FCFY3.06%
OCF(TTM)0.34
OCFY5.57%
SpS8.07
BVpS2.9
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.97%
FCFM 2.3%
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Debt/EBITDA 92.65
Cap/Depr 42.02%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion 1459.7%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.37
Altman-Z 1.52
F-Score3
WACC5.84%
ROIC/WACCN/A
Cap/Depr(3y)51.6%
Cap/Depr(5y)53.6%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
EPS Next Y146.79%
EPS Next 2Y77.13%
EPS Next 3Y56.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A
EBIT growth 1Y-63.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year298.91%
EBIT Next 3Y81.16%
EBIT Next 5YN/A
FCF growth 1Y236.99%
FCF growth 3YN/A
FCF growth 5Y-12.09%
OCF growth 1Y522.93%
OCF growth 3YN/A
OCF growth 5Y-6.11%